Willcox B E, Gao G F, Wyer J R, O'Callaghan C A, Boulter J M, Jones E Y, van der Merwe P A, Bell J I, Jakobsen B K
MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.
Protein Sci. 1999 Nov;8(11):2418-23. doi: 10.1110/ps.8.11.2418.
A method to produce alphabeta T-cell receptors (TCRs) in a soluble form suitable for biophysical analysis was devised involving in vitro refolding of a TCR fusion protein. Polypeptides corresponding to the variable and constant domains of each chain of a human and a murine receptor, fused to a coiled coil heterodimerization motif from either c-Jun (alpha) or v-Fos (beta), were overexpressed separately in Escherichia coli. Following recovery from inclusion bodies, the two chains of each receptor were denatured, and then refolded together in the presence of denaturants. For the human receptor, which is specific for the immunodominant influenza A HLA-A2-restricted matrix epitope (M58-66), a heterodimeric protein was purified in milligram yields and found to be homogeneous, monomeric, antibody-reactive, and stable at concentrations lower than 1 microM. Using similar procedures, analogous results were obtained with a murine receptor specific for an influenza nucleoprotein epitope (366-374) restricted by H2-Db. Production of these receptors has facilitated a detailed analysis of viral peptide-Major Histocompatibility Complex (peptide-MHC) engagement by the TCR using both surface plasmon resonance (SPR) and, in the case of the human TCR, isothermal titration calorimetry (ITC) (Willcox et al., 1999). The recombinant methods described should enable a wide range of TCR-peptide-MHC interactions to be studied and may also have implications for the production of other heterodimeric receptor molecules.
设计了一种生产适用于生物物理分析的可溶性αβ T细胞受体(TCR)的方法,该方法涉及TCR融合蛋白的体外重折叠。将与人和鼠受体各链的可变区和恒定区相对应的多肽,与来自c-Jun(α链)或v-Fos(β链)的卷曲螺旋异源二聚化基序融合,分别在大肠杆菌中过表达。从包涵体中回收后,每个受体的两条链被变性,然后在变性剂存在下一起重折叠。对于特异性识别免疫显性甲型流感病毒HLA-A2限制性基质表位(M58-66)的人源受体,以毫克产量纯化得到一种异源二聚体蛋白,发现其具有均一性、单体性、抗体反应性,并且在浓度低于1μM时稳定。使用类似的程序,对于特异性识别受H2-Db限制的流感病毒核蛋白表位(366-374)的鼠源受体,也获得了类似的结果。这些受体的生产有助于使用表面等离子体共振(SPR)以及(对于人源TCR而言)等温滴定量热法(ITC)对TCR与病毒肽-主要组织相容性复合体(肽-MHC)的结合进行详细分析(Willcox等人,1999年)。所描述的重组方法应能使广泛的TCR-肽-MHC相互作用得到研究,并且可能对其他异源二聚体受体分子的生产也有影响。